US Drug Recall Register
Class II · Moderate risk Ongoing Initiated Nov 19, 2024 (2 years ago)

Duloxetine Delayed-Release Capsules USP, 20 mg, 60 count bottles, Rx only, Distributed…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit

What was recalled

Duloxetine Delayed-Release Capsules USP, 20 mg, 60 count bottles, Rx only, Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ NDC 57237-017-60

Recalling firm
Rising Pharma Holding, Inc.
NDC code
57237-017-60
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0105-2025

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other East recalls

See all